<DOC>
	<DOCNO>NCT00002899</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Adjuvant radiation therapy may kill remain tumor cell follow surgery radiosurgery brain metastasis . PURPOSE : This randomized phase III trial study surgery radiosurgery alone see well work compare surgery radiosurgery whole-brain radiation therapy treat brain metastasis patient solid tumor .</brief_summary>
	<brief_title>Adjuvant Radiation Therapy Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : Primary - Investigate efficacy toxicity adjuvant whole brain radiotherapy prior surgical resection radiosurgery 1 3 brain metastasis solid tumor patient good performance status control systemic cancer . Secondary - Determine overall survival progression-free survival patient treat protocol . - Determine time neurologic progression patient treat protocol . - Determine quality life patient treat protocol . OUTLINE : This randomize , multicenter study . Patients stratify participate center , number brain metastasis ( single v multiple ) , type primary tumor ( stable systemic cancer v synchronous unknown primary ) , WHO performance status ( 0-1 v 2 ) , treatment ( prior surgical resection v plan radiosurgery ) . Patients undergone complete surgical resection randomize 1 2 treatment arm within 4 week surgery . - Arm I : Patients undergo adjuvant whole brain radiotherapy ( WBRT ) . - Arm II : Patients receive adjuvant radiotherapy . Patients plan undergo radiosurgery randomize 1 2 treatment arm . - Arm III : Patients undergo radiosurgery follow adjuvant WBRT within 4 week surgery . - Arm IV : Patients undergo radiosurgery alone . Quality life assess baseline , 8 week , every 3 month thereafter . After completion study treatment , patient follow 8 week every 3 month thereafter . PROJECTED ACCRUAL : A total 340 patient ( 85 per treatment arm ) accrue study within 3.5 year .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis brain metastasis histologically confirm primary metastatic extracranial tumor , meet 1 follow criterion : Stable systemic cancer last 3 month ( achieve surgery , radiotherapy , chemotherapy , hormonal therapy ) , define absence symptomatic radiological progression Asymptomatic synchronous primary tumor ( treatable surgery , radiotherapy , chemotherapy , hormonal therapy ) No metastasis outside CNS Unknown primary tumor Must one three brain lesion , confirm enhanced MRI prior radiosurgery surgery No brain stem metastases No leptomeningeal metastases No brain metastases small cell lung cancer , lymphoma , leukemia , myeloma , germ cell tumor Patients plan undergo radiosurgery must meet following criterion : Largest diameter ≤ 3.5 cm single metastasis Largest diameter ≤ 2.5 cm multiple metastases Stereotactic biopsy require extracranial tumor ( unknown primary tumor ) OR extracranial diagnosis make 4 year previously Prior neurosurgery patient must undergo complete surgical resection No recurrent brain metastasis prior surgery and/or radiosurgery and/or brain radiotherapy PATIENT CHARACTERISTICS : Age 18 Performance status WHO 02 ( may assess steroid therapy ) Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics No concurrent chemotherapy whole brain radiotherapy Endocrine therapy See Disease Characteristics Radiotherapy See Disease Characteristics Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>tumor metastatic brain</keyword>
</DOC>